Business Context and Reporting Period
This Form 8-K Current Report was filed by Astrotech Corporation (NASDAQ: ASTC) on April 6, 2021, covering the event date of March 31, 2021. The registrant is incorporated in Delaware and operates from Austin, Texas.
Key Financial Metrics
This filing is a Current Report regarding a specific corporate event and does not provide financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial data is disclosed in this document.
Material Changes
The material event reported is the execution of an Investigator-Initiated Study Agreement on March 31, 2021, between Astrotech's subsidiary, BreathTech Corporation, and the Cleveland Clinic Foundation.
- Study Objective: To compare exhaled breath from individuals with positive COVID-19 PCR tests against those with negative results.
- Technology: The study utilizes BreathTech's BreathTest-1000 device.
- Goal: To analyze volatile organic compounds in breath to evaluate correlations with different disease states.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or management commentary regarding future performance. No specific risks or contingencies are detailed beyond the standard nature of a pilot study. The agreement is attached as Exhibit 99.1, with certain portions omitted for confidential treatment.
Investor Verification Checklist
- Verify the terms and duration of the Investigator-Initiated Study Agreement in Exhibit 99.1.
- Confirm the commercial status and regulatory approval of the BreathTest-1000 device.
- Review subsequent filings for results of the pilot study with the Cleveland Clinic.
- Check the company's latest 10-K or 10-Q for actual financial performance data, as this 8-K contains none.